Pharmacologic Treatment for Orthostatic Hypotension in Older Adults
Midodrine is the first-line pharmacologic agent for symptomatic orthostatic hypotension in older adults, with droxidopa as an alternative, particularly in patients with neurogenic causes such as Parkinson disease. 1
Treatment Algorithm
Step 1: Non-Pharmacologic Interventions First
Before initiating medications, implement these foundational strategies:
- Medication review and withdrawal of offending agents (diuretics, vasodilators, antihypertensives) 1
- Acute water ingestion (≥480 mL) provides temporary relief within 30 minutes 1
- Increased salt intake (6-9 g or 1-2 teaspoons daily) and fluid supplementation 1
- Compression garments (at least thigh-high, preferably including abdomen) 1
- Physical counter-pressure maneuvers (leg crossing, squatting, lower body muscle tensing) 1
Step 2: First-Line Pharmacologic Therapy
Midodrine is the primary medication choice:
- Improves symptoms through dose-dependent increases in standing blood pressure 1
- Limitation: Supine hypertension is the main concern
- Common side effects: scalp tingling, piloerection, urinary retention 1
Droxidopa as alternative or in specific populations:
- Particularly effective for neurogenic OH from Parkinson disease, pure autonomic failure, and multiple system atrophy 1
- May reduce falls according to small studies 1
- Important caveat: Carbidopa (used in Parkinson disease) may decrease droxidopa effectiveness 1
- Side effects: supine hypertension, headache, dizziness, nausea 1
Step 3: Second-Line Pharmacologic Options
Fludrocortisone:
- Increases plasma volume, improving OH symptoms 1
- Critical consideration: Should be used AFTER other medications when supine hypertension is present 1
- Side effects: edema, hypokalemia, headache
- Serious warning: Doses >0.3 mg daily risk adrenal suppression and immunosuppression 1
Step 4: Refractory Cases
For patients unresponsive to standard therapy:
Pyridostigmine:
- Improves orthostatic tolerance through increased peripheral vascular resistance 1
- Side effects: nausea, vomiting, abdominal cramping, sweating, urinary incontinence 1
Octreotide:
- Specifically for postprandial or refractory neurogenic OH 1
- Reduces splanchnic blood flow by ~20%, preventing postprandial hypotension 1
Critical Clinical Pitfalls
Supine Hypertension Management
This is the most common limiting factor in OH treatment. When present:
- Avoid fludrocortisone as first-line 1
- Monitor blood pressure in both supine and standing positions
- Consider timing medications to avoid nighttime supine hypertension
Contraindications for Salt/Fluid Supplementation
Do NOT increase salt and fluid in patients with:
- History of hypertension
- Renal disease
- Heart failure
- Cardiac dysfunction 1
The long-term effects of increased salt/fluid intake remain unknown in these populations 1.
Medication-Induced OH
Always review and discontinue causative medications first 1. This is particularly crucial in older adults with polypharmacy, where syncope from medications is highly prevalent 1. Cessation of offending drugs is usually key for symptomatic improvement, though feasibility may be limited by treatment necessity 1.
Emerging Considerations
While conventional vasoconstriction remains the mainstay, emerging strategies including norepinephrine transporter inhibition and mechanism-based treatment selection informed by physiological phenotyping may become increasingly important 2. However, these remain investigational and should not guide current clinical practice.